Hyperbaric Oxygen Therapy for Intracranial Abscess

The Surprising Science of Using Oxygen to Fight Brain Infections

An intracranial abscess (ICA) is a medical emergency that often begins in the shadows of the mundane. Whether manifesting as a cerebral abscess, a subdural empyema, or an epidural empyema, an ICA represents a collection of infected material within the skull - a literal "hidden emergency" that can arise from a simple sinus headache or a neglected dental infection. Yet the reach of this invader is broader than mere hygiene; it strikes children with cyanotic congenital heart disease and appears as a devastating complication of intravenous drug use.

While the incidence is relatively low - affecting between 0.4 and 0.9 people per 100,000 in the United States annually - the stakes are absolute. In 1960, an ICA was frequently a death sentence, with mortality rates hovering around 40%. Today, thanks to refined imaging and minimally invasive surgery, that number has plummeted to 10%. However, for those in the "refractory" category - where standard drugs and surgeries fail - the pressure is on to find a more effective solution.

The mouth-brain connection: a counter-intuitive culprit

To understand how to fight these infections, we must first look at where they come from. Investigative data reveals a surprising truth: many brain abscesses are caused by the "normal residents" of the human body. Between 30% and 50% of cases occur due to "contiguous spread", where bacteria from a nearby site - such as the sinuses or ears - migrate into the brain.

The primary culprits are often bacteria from the Viridans group, specifically Streptococcus intermedius, S. constellatus, and S. anginosus. While we might expect these in the oral cavity, they are also standard inhabitants of the appendix and the female genital tract. They possess a unique "proclivity for abscess formation" once they breach the blood-brain barrier.

"The aforementioned organisms [Streptococcus intermedius, constellatus, and anginosus] are distinct from Streptococcus pyogenes and Streptococcus pneumoniae, which are rare causes of bacterial brain abscess."

This distinction is vital for clinical investigative work. These organisms are not the common triggers for strep throat or pneumonia; they are specialised invaders that thrive in the unique, low-oxygen niches of the cranium.

The low-oxygen trap: why fungal infections are deadly

While bacteria are the primary suspects, fungal infections like Aspergillus or those from the Mucorales family represent a lethal subset of ICAs. These fungi are "angioinvasive", meaning they attack and block blood vessels, causing thrombophlebitis. This leads to local tissue death (necrosis) and creates a biological "catch-22".

This process results in a low-oxygen environment characterised by metabolic acidosis. In this acidic, oxygen-starved state, the body's primary defenders - neutrophils and macrophages - become paralysed. They require oxygen to perform the "respiratory burst" necessary to kill pathogens. By destroying the local blood supply, the infection effectively builds a fortress that keeps the immune system out, rendering traditional treatments nearly useless in these necrotic "dead zones".

Takeaway 1: HBO₂ is an antibiotic force multiplier

Takeaway 2: fighting swelling without steroids

The "refractory" criteria: when pressure becomes the last resort

HBO₂ is not a first-line treatment for every patient, but it becomes a vital adjunct when the clinical picture darkens. According to established treatment flowcharts, HBO₂ should be strongly considered when a patient presents with predictors of poor outcome or fails to respond to initial care. The specific criteria include:

• Multiple abscesses or those in a deep or dominant location: targeting areas that control speech or motor skills where surgery is high-risk.
• Glasgow Coma Scale (GCS) score less than nine: indicating severe neurological compromise.
• Compromised host: particularly those with HIV, malignancy, or diabetes (who are prone to rhinocerebral mucormycosis).
• Failure to respond: continued deterioration despite targeted antibiotics and standard surgical interventions (such as one or two needle aspirations).

Success in extremis: from infants to teens

The clinical evidence for HBO₂ is growing through impactful series and case reports. One study of 25 consecutive patients treated with adjunctive HBO₂ reported a 0% mortality rate, with 73% of patients achieving a complete recovery. Recent cases illustrate the therapy's power in desperate scenarios:

• Rhino-orbital-cerebral mucormycosis (ROCM): a 2021 series successfully used HBO₂ to treat this aggressive fungal infection, which typically thrives in the acidic environments of diabetic patients. Six out of seven patients in the study showed complete resolution after 40-60 treatments.
• The 16-year-old recovery: a previously healthy teenager with multiple abscesses caused by Fusobacterium failed to improve after four surgeries. After initiating HBO₂ at 2.8 ATA, he showed significant improvement after the first treatment and made a full recovery after 37 sessions.
• The 8-month-old infant: HBO₂ was successfully utilised to treat a posterior fossa epidural abscess, proving the therapy's safety and efficacy even in paediatric patients.

Conclusion: the future of high-pressure healing

The battle against intracranial abscesses has transitioned from a 40% mortality rate in 1960 to a 10% rate today. This progress is a triumph of modern medicine, yet for the most difficult, "unreachable" infections, HBO₂ remains an essential tool. By reversing metabolic acidosis and re-oxygenating necrotic tissue, HBO₂ breaks the cycle of immune failure.

As we look forward, the success of oxygen in the brain suggests a broader potential. If hyperbaric pressure can solve an infection hidden deep within the cranium or lingering in the bone of the skull (as seen in concomitant skull osteomyelitis), could it be the key to solving other "unreachable" or antibiotic-resistant infections throughout the body? For patients under the most extreme pressure, high-pressure oxygen is proving to be more than just a breath of air - it is a lifeline.

This feature article is general educational information and does not replace advice from your own doctor. Whether hyperbaric oxygen is appropriate depends on your individual circumstances. Portions were drafted with the assistance of AI tools and reviewed by Dr Gregory Weir; please verify clinical details against primary sources.